Concepts (115)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Students, Medical | 8 | 2025 | 265 | 2.310 |
Why?
|
| Focus Groups | 3 | 2024 | 328 | 0.990 |
Why?
|
| Attitude of Health Personnel | 4 | 2025 | 628 | 0.880 |
Why?
|
| Physicians | 4 | 2021 | 482 | 0.820 |
Why?
|
| Students, Nursing | 1 | 2025 | 99 | 0.770 |
Why?
|
| Education, Medical, Undergraduate | 3 | 2024 | 162 | 0.770 |
Why?
|
| Obstetrics | 1 | 2024 | 91 | 0.760 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2023 | 93 | 0.700 |
Why?
|
| Counseling | 1 | 2024 | 376 | 0.690 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2023 | 192 | 0.660 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2025 | 769 | 0.630 |
Why?
|
| Curriculum | 6 | 2025 | 610 | 0.600 |
Why?
|
| Education | 1 | 2019 | 66 | 0.590 |
Why?
|
| Opioid-Related Disorders | 1 | 2025 | 529 | 0.540 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 3 | 2023 | 24 | 0.440 |
Why?
|
| Learning | 2 | 2019 | 186 | 0.350 |
Why?
|
| Medical Errors | 3 | 2006 | 202 | 0.310 |
Why?
|
| Cognitive Dissonance | 1 | 2009 | 5 | 0.300 |
Why?
|
| Marketing | 1 | 2009 | 21 | 0.290 |
Why?
|
| Ethics, Medical | 1 | 2009 | 40 | 0.290 |
Why?
|
| Conflict of Interest | 1 | 2009 | 38 | 0.290 |
Why?
|
| Drug Industry | 1 | 2009 | 41 | 0.290 |
Why?
|
| Qualitative Research | 3 | 2024 | 757 | 0.240 |
Why?
|
| Fetal Viability | 1 | 2024 | 6 | 0.210 |
Why?
|
| Schools, Medical | 3 | 2020 | 150 | 0.200 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2009 | 708 | 0.200 |
Why?
|
| Cesarean Section | 1 | 2024 | 102 | 0.190 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2023 | 22 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2023 | 104 | 0.190 |
Why?
|
| Cell Line, Tumor | 3 | 2023 | 1567 | 0.180 |
Why?
|
| Massachusetts | 5 | 2024 | 2153 | 0.180 |
Why?
|
| Sulfonamides | 1 | 2023 | 133 | 0.180 |
Why?
|
| Humans | 15 | 2025 | 65462 | 0.170 |
Why?
|
| Palliative Care | 1 | 2024 | 250 | 0.170 |
Why?
|
| Adult | 4 | 2025 | 17460 | 0.170 |
Why?
|
| Licensure | 1 | 2020 | 14 | 0.160 |
Why?
|
| Social Skills | 1 | 2019 | 12 | 0.160 |
Why?
|
| Communication | 2 | 2024 | 600 | 0.150 |
Why?
|
| Internal Medicine | 3 | 2011 | 154 | 0.150 |
Why?
|
| Interdisciplinary Communication | 1 | 2019 | 106 | 0.150 |
Why?
|
| Pandemics | 2 | 2021 | 682 | 0.140 |
Why?
|
| Universities | 1 | 2019 | 169 | 0.140 |
Why?
|
| Internship and Residency | 1 | 2006 | 803 | 0.140 |
Why?
|
| Education, Medical | 1 | 2019 | 183 | 0.130 |
Why?
|
| Male | 5 | 2025 | 31186 | 0.130 |
Why?
|
| Leadership | 1 | 2019 | 212 | 0.130 |
Why?
|
| Apoptosis | 1 | 2023 | 1098 | 0.130 |
Why?
|
| Health Policy | 1 | 2019 | 191 | 0.130 |
Why?
|
| Program Evaluation | 1 | 2019 | 498 | 0.130 |
Why?
|
| Pregnancy | 1 | 2024 | 2391 | 0.130 |
Why?
|
| Female | 5 | 2025 | 34193 | 0.120 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2016 | 51 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2016 | 32 | 0.120 |
Why?
|
| Translocation, Genetic | 1 | 2016 | 74 | 0.120 |
Why?
|
| Research Design | 1 | 2019 | 590 | 0.120 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2016 | 59 | 0.120 |
Why?
|
| Health Personnel | 1 | 2019 | 389 | 0.110 |
Why?
|
| Disease Models, Animal | 1 | 2023 | 2305 | 0.110 |
Why?
|
| Quality Improvement | 1 | 2019 | 468 | 0.110 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2016 | 218 | 0.110 |
Why?
|
| Antineoplastic Agents | 2 | 2016 | 642 | 0.110 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 529 | 0.100 |
Why?
|
| Mice | 2 | 2023 | 11137 | 0.080 |
Why?
|
| Proteins | 1 | 2016 | 764 | 0.080 |
Why?
|
| Clinical Clerkship | 1 | 2011 | 94 | 0.080 |
Why?
|
| Interprofessional Relations | 1 | 2011 | 137 | 0.080 |
Why?
|
| Teaching | 2 | 2006 | 165 | 0.070 |
Why?
|
| Animals | 2 | 2023 | 21380 | 0.060 |
Why?
|
| Truth Disclosure | 1 | 2006 | 58 | 0.060 |
Why?
|
| Preceptorship | 1 | 2005 | 42 | 0.060 |
Why?
|
| Attitude to Health | 1 | 2006 | 296 | 0.050 |
Why?
|
| Faculty, Medical | 1 | 2005 | 200 | 0.050 |
Why?
|
| Emotions | 1 | 2006 | 233 | 0.050 |
Why?
|
| General Surgery | 1 | 2006 | 210 | 0.050 |
Why?
|
| Patient Satisfaction | 1 | 2006 | 441 | 0.050 |
Why?
|
| Physician-Patient Relations | 1 | 2006 | 425 | 0.050 |
Why?
|
| Critical Illness | 1 | 2024 | 339 | 0.040 |
Why?
|
| Interrupted Time Series Analysis | 1 | 2019 | 30 | 0.040 |
Why?
|
| Primary Health Care | 1 | 2005 | 723 | 0.040 |
Why?
|
| Sample Size | 1 | 2019 | 67 | 0.040 |
Why?
|
| Betacoronavirus | 1 | 2020 | 180 | 0.040 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 205 | 0.030 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 219 | 0.030 |
Why?
|
| Bcl-2-Like Protein 11 | 1 | 2016 | 20 | 0.030 |
Why?
|
| bcl-X Protein | 1 | 2016 | 24 | 0.030 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2016 | 31 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2019 | 485 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2016 | 128 | 0.030 |
Why?
|
| Azepines | 1 | 2016 | 22 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2016 | 30 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2016 | 33 | 0.030 |
Why?
|
| Triazoles | 1 | 2016 | 63 | 0.030 |
Why?
|
| Multigene Family | 1 | 2016 | 106 | 0.030 |
Why?
|
| Drug Discovery | 1 | 2016 | 96 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2016 | 201 | 0.030 |
Why?
|
| Drug Design | 1 | 2016 | 137 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2016 | 119 | 0.030 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2016 | 100 | 0.030 |
Why?
|
| Cell Survival | 1 | 2016 | 587 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 312 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 687 | 0.020 |
Why?
|
| United States | 2 | 2020 | 8148 | 0.020 |
Why?
|
| Aged | 1 | 2009 | 15051 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2016 | 1039 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2016 | 907 | 0.020 |
Why?
|
| Middle Aged | 1 | 2009 | 18386 | 0.020 |
Why?
|
| Canada | 1 | 2011 | 157 | 0.020 |
Why?
|
| Surveys and Questionnaires | 2 | 2011 | 2776 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2011 | 288 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2016 | 712 | 0.020 |
Why?
|
| Malpractice | 1 | 2006 | 20 | 0.020 |
Why?
|
| Health Maintenance Organizations | 1 | 2006 | 61 | 0.010 |
Why?
|
| Video Recording | 1 | 2006 | 140 | 0.010 |
Why?
|
| Family Practice | 1 | 2005 | 215 | 0.010 |
Why?
|
| Pediatrics | 1 | 2005 | 264 | 0.010 |
Why?
|